Antineoplaston Therapy in Treating Patients With Soft Tissue Sarcoma
Status:
Terminated
Trial end date:
2003-08-30
Target enrollment:
Participant gender:
Summary
Current therapies for Soft Tissue Sarcoma provide very limited benefit to the patient. The
anti-cancer properties of Antineoplaston therapy suggest that it may prove beneficial in the
treatment of Soft Tissue Sarcoma.
PURPOSE: This study is being performed to determine the effects (good and bad) that
Antineoplaston therapy has on patients with Soft Tissue Sarcoma.